Additional retrospective studies, utilizing cortical specimens from individuals with a confirmed COVID-19 history, are required to establish whether ACE2 and/or TMPRSS2 protein expression levels are associated with the infectivity and neurological complications in different categories of aged individuals. This evidence concerns the gene ACE2 and COVID-19.